Solventum Mobile Microphone vs BoneCalc

The Solventum Mobile Microphone is a mobile application that allows clinicians to dictate using the Solventum Fluency Direct Desktop Application without the need for a physical microphone attached to the PC. Once the mobile application is paired one time with a Solventum Fluency Direct User ID, the user of the application can dictate using Solventum Fluency Direct running on any physical desktop or virtual device without a need for docking, Bluetooth or physical connections. The application uses secure data transmission to stream audio from the mobile device directly to Solventum Fluency Direct running elsewhere. It builds on the same cloud-based Solventum Speech Understanding (tm) technology powering all Solventum solutions, so existing clinician voice profiles can be used easily and instantly for optimal accuracy.

The BoneCalc app is designed for the calculation of Z-scores and percentiles for bone mineral content (BMC) and areal bone mineral density (aBMD) for children under 20 years of age, as measured by dual-energy X-ray absorptiometry (DXA), for the following sites: whole-body subtotal (total-body-less-head), total hip, femoral neck, lumbar spine, distal ⅓ radius and ultradistal radius. Separate race-specific (Black and non-Black) and race-neutral calculations are available by age and sex. Height-Z–adjusted Z-scores for these measures are also calculated. The BMC and aBMD data are derived from the CHOP Bone Mineral Density in Childhood Study: race-specific for ages 5–20 [Zemel B et al., J Clin Endocrinol Metab 2011;96(10):3160–3169]; race-specific for ages 1–5 [Kalkwarf HJ et al., J Clin Endocrinol Metab 2022;107(9):e3887–e3900]; and race-neutral ages 5–20 [Zemel BS et al., J Clin Endocrinol Metab 2025;110(11):3034–3048]. Calculations are also available for lumbar-spine bone mineral apparent density (BMAD) for children 5–20 years of age: race-specific [Kindler JM et al. J Clin Endocrinol Metab 2019;104(4):1283–1292] and race-neutral [Zemel BS et al., J Clin Endocrinol Metab 2025;110(11):3034–3048].